Skip to main content
SpringerLink
Log in

Resection Versus SBRT for Stage I Non-small Cell Lung Cancer in Patients with Good Pulmonary Function

  • Chapter
  • First Online:
Difficult Decisions in Thoracic Surgery

Part of the book series: Difficult Decisions in Surgery: An Evidence-Based Approach ((DDSURGERY,volume 1))

  • 1344 Accesses

Abstract

Anatomic pulmonary resection with systematic lymph node sampling remains the accepted standard for patients with clinical stage I NSCLC. The widespread use of diagnostic chest computed tomography particularly for lung cancer screening has identified smaller tumors. Stereotactic body radiation therapy (SBRT) has emerged as an alternative for medically inoperable patients harboring stage I NSCLC. Results from phase II prospective clinical trials have demonstrated that SBRT is highly effective at primary tumor control while avoiding serious toxicity. The efficacy of SBRT in operable patients with stage I NSCLC is under investigation and evidence to compare treatment equivalency to surgical resection is lacking.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–22.

    Article  CAS  PubMed  Google Scholar 

  2. Keenan RJ, Landreneau RJ, Maley Jr RH, et al. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg. 2004;78:228–33.

    Article  PubMed  Google Scholar 

  3. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I NSCLC. Ann Thorac Surg. 2006;82(2):408–15.

    Article  PubMed  Google Scholar 

  4. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized NSCLC: a multicenter study. J Thorac Cardiovasc Surg. 2006;132(4):769–75.

    Article  PubMed  Google Scholar 

  5. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2:S94–100.

    Article  PubMed  Google Scholar 

  6. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non–small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27:3290–6.

    Article  PubMed  Google Scholar 

  7. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. J Am Med Assoc. 2010;303:1070–6.

    Article  CAS  Google Scholar 

  8. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007;2(8):706–14.

    Article  PubMed  Google Scholar 

  9. Schuchert MJ, Abbas G, Awais O. Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg. 2012;93(6):1780–5.

    Article  PubMed  Google Scholar 

  10. Fan J, Wang L, Jiang GN, Gao W. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies. Ann Surg Oncol. 2012;19(2):661–8.

    Article  PubMed  Google Scholar 

  11. Tsutani Y, Miyata Y, Nakayama H, et al. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score–matched analysis in a multicenter study. J Thorac Cardiovasc Surg. 2013;146(2):358–64.

    Article  PubMed  Google Scholar 

  12. Fernando HC, Santos RS, Benfield JR, Grannis FW, Keenan RJ, Luketich JD, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:261–7.

    Article  PubMed  Google Scholar 

  13. Shibamoto Y, Hashizume C, Baba F, et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer. Cancer. 2012;118(8):2078–84.

    Article  PubMed  Google Scholar 

  14. Grills IS, Hope AJ, Guckenberger M, et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol. 2012;7(9):1382–93.

    Article  PubMed  Google Scholar 

  15. Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys. 2009;75:677–82.

    Article  PubMed  Google Scholar 

  16. Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer. 2010;68:72–7.

    Article  PubMed  Google Scholar 

  17. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S. Stage I non small cell lung cancer in patients aged > or = 75 years: outcomes after stereotactic radiotherapy. Cancer. 2010;116:406–14.

    Article  PubMed  Google Scholar 

  18. Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685–92.

    Article  PubMed  Google Scholar 

  19. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011;81:1352–8.

    Article  PubMed  Google Scholar 

  20. Barriger RB, Forquer JA, Brabham JG. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012;82(1):457–62.

    Article  PubMed  Google Scholar 

  21. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–9.

    Article  PubMed  Google Scholar 

  22. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol. 2011;6:2036–43.

    Article  PubMed  Google Scholar 

  23. Crabtree TD, Denlinger CE, Meyers BF. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2010;140(2):377–86.

    Article  PubMed  Google Scholar 

  24. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28:928–35.

    Article  PubMed  Google Scholar 

  25. Puri V, Crabtree TD, Kymes S, et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. J Thorac Cardiovasc Surg. 2012;143(2):428–36.

    Article  PubMed  Google Scholar 

  26. Verstegen NE, Oosterhuis JW, Palma DA, et al. Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by VATS: outcomes of a propensity score-matched analysis. Ann Oncol. 2013;24(6):1543–8.

    Article  CAS  PubMed  Google Scholar 

  27. Boffa DJ, Kosinski AS, Paul S, Mitchell JD, Onaitis M. Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg. 2012;94(2):347–53.

    Article  PubMed  Google Scholar 

  28. Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141(3):662–70.

    Article  PubMed  Google Scholar 

  29. Mahmood S, Bilal H, Faivre-Finn C, Shah R. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with Stage I NSCLC? Interact Cardiovasc Thorac Surg. 2013;17(5):845–53.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Blake 1570, Boston, MA, 02114, USA

    Michael Lanuti MD

Authors
  1. Michael Lanuti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Lanuti MD .

Editor information

Editors and Affiliations

  1. Surgery, University of Chicago, Chicago, Illinois, USA

    Mark K. Ferguson

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Lanuti, M. (2014). Resection Versus SBRT for Stage I Non-small Cell Lung Cancer in Patients with Good Pulmonary Function. In: Ferguson, M. (eds) Difficult Decisions in Thoracic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach, vol 1. Springer, London. https://doi.org/10.1007/978-1-4471-6404-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6404-3_15

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6403-6

  • Online ISBN: 978-1-4471-6404-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation